Short Interest in GP-Act III Acquisition Corp. (NASDAQ:GPAT) Decreases By 18.9%
by Mitch Edgeman · The Markets DailyGP-Act III Acquisition Corp. (NASDAQ:GPAT – Get Free Report) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling 1,855 shares, a decrease of 18.9% from the November 30th total of 2,287 shares. Based on an average daily volume of 2,526 shares, the short-interest ratio is currently 0.7 days. Based on an average daily volume of 2,526 shares, the short-interest ratio is currently 0.7 days.
Institutional Investors Weigh In On GP-Act III Acquisition
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Alberta Investment Management Corp acquired a new position in GP-Act III Acquisition during the second quarter valued at approximately $17,144,000. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of GP-Act III Acquisition in the second quarter worth $2,638,000. Wolverine Asset Management LLC boosted its holdings in shares of GP-Act III Acquisition by 62.1% during the 2nd quarter. Wolverine Asset Management LLC now owns 501,000 shares of the company’s stock worth $5,286,000 after buying an additional 191,950 shares during the period. Meteora Capital LLC acquired a new position in GP-Act III Acquisition in the 2nd quarter valued at $20,330,000. Finally, Wealthspring Capital LLC raised its holdings in GP-Act III Acquisition by 406.1% in the 2nd quarter. Wealthspring Capital LLC now owns 1,059,042 shares of the company’s stock worth $11,173,000 after acquiring an additional 849,783 shares during the period.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, GP-Act III Acquisition presently has a consensus rating of “Sell”.
View Our Latest Report on GPAT
GP-Act III Acquisition Stock Up 0.0%
Shares of GPAT stock traded up $0.01 on Wednesday, hitting $10.70. The company’s stock had a trading volume of 2,128 shares, compared to its average volume of 83,278. GP-Act III Acquisition has a fifty-two week low of $10.14 and a fifty-two week high of $10.72. The firm’s fifty day moving average price is $10.67 and its 200-day moving average price is $10.61.
GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last posted its earnings results on Thursday, November 13th. The company reported $0.09 earnings per share for the quarter.
About GP-Act III Acquisition
GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.
Featured Stories
- Five stocks we like better than GP-Act III Acquisition
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off